Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Zhongguo Zhong Yao Za Zhi ; 44(6): 1208-1215, 2019 Mar.
Article in Chinese | MEDLINE | ID: mdl-30989985

ABSTRACT

Fingerprints of lipophilic components in the roots of Salvia miltiorrhiza and S.yunnanensis were analyzed by UPLC-DADand UPLC coupled with mass spectroscopy to evaluate the differences and similarities of the lipophilic components in the two kinds of herbs.The UPLC analysis of 18 batches of S.miltiorrhiza and 16 batches of S.yunnanensis was performed on a 25℃Thermo Accucore C_(18)column(2.1 mm×100 mm,2.6µm)by Shimadzu LC-20AD;mobile phase was 0.026%phosphoric acid(A)-acetonitrile(B)with gradient elution;flow rate was 0.4 m L·min~(-1);detection wavelength was set at 270 nm;injection volume was 2µL.The molecular structures of the lipophilic components were analyzed on a 25℃Thermo Accucore C_(18)column(2.1 mm×100 mm,2.6µm)by Thermo U3000 UPLC Q Exactive Orbitrap LC-MS/MS with a mobile phaseconsisting of 0.1%formic acid water(A)and 0.1%formic acidacetonitrile(B).The mass spectrometry was acquired in positive modes using ESI.There are 10 common peaks in the lipophilic components of S.miltiorrhiza.The similarity between the 16 batches of S.miltiorrhiza and their own reference spectra was greater than 0.942,and the average similarity was 0.973.There are 12 common peaks in the lipophilic components of S.yunnanensis.The similarity between the 18 batches of S.yunnanensis and their own reference spectra was greater than 0.937,and the average similarity was 0.976.The similarity between the reference chromatograms of S.miltiorrhiza and S.yunnanensis was only 0.900.There are three lipophilic components in S.yunnanensis,which are not found in S.miltiorrhiza,and one of which isα-lapachone.There is a lipophilic component in S.miltiorrhiza not found in S.yunnanensis,which may be miltirone.The two herbs contain 8 common lipophilic components including dihydrotanshinoneⅠ,cryptotanshinone,tanshinoneⅠ,tanshinoneⅡ_A,nortanshinone in which the content of tanshinoneⅡ_A,dihydrotanshinoneⅠand cryptotanshinone of S.yunnanensisis significantly lower than that of S.miltiorrhiza(P<0.01),and the contents of tanshinoneⅠand nortanshinone are significantly lower than that of S.miltiorrhiza too(P<0.05).There are significant differences in the types and contents of lipophilic components between the roots of S.miltiorrhiza and S.yunnanensis,and the similarity between the fingerprints of interspecies is much lower than that between the same species.Therefore,the roots of S.miltiorrhiza and S.yunnanensis are two kinds of herbs which are quite different in chemical compounds and compositions.


Subject(s)
Salvia miltiorrhiza , Abietanes , Chromatography, Liquid , Molecular Structure , Plant Roots , Tandem Mass Spectrometry
2.
Int J Biol Sci ; 15(2): 416-429, 2019.
Article in English | MEDLINE | ID: mdl-30745831

ABSTRACT

To obtain insight into the function of miRNAs in the synthesis and storage of important nutrients during the development of Camellia oleifera fruit, Illumina sequencing of flower and fruit small-RNA was conducted. The results revealed that 797 miRNAs were significantly differentially expressed between flower and fruit samples of Camellia oleifera. Through integrated GO and KEGG function annotations, it was determined that the miRNA target genes were mainly involved in metabolic pathways, plant hormone signal transduction, fruit development, mitosis and regulation of biosynthetic processes. Carbohydrate accumulation genes were differentially regulated by miR156, miR390 and miR395 in the fruit growth and development process. MiR477 is the key miRNA functioning in regulation of genes and involved in fatty acid synthesis. Additionally, miR156 also has the function of regulating glycolysis and nutrient transformation genes.


Subject(s)
Camellia/chemistry , Fruit/metabolism , MicroRNAs/metabolism , RNA, Plant/genetics , Flowers/genetics , Flowers/metabolism , Fruit/genetics , Gene Expression Profiling , Gene Expression Regulation, Plant/genetics , Gene Expression Regulation, Plant/physiology , High-Throughput Nucleotide Sequencing , MicroRNAs/genetics , Microscopy, Electron, Scanning
3.
PLoS One ; 9(12): e114792, 2014.
Article in English | MEDLINE | ID: mdl-25501752

ABSTRACT

BACKGROUND: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by the production of autoantibodies. To date, no therapy has been found to satisfactorily treat SLE. SIRT1 deficiency results in the development of an autoimmune syndrome in mice, including a high titer of anti-nuclear antibody in serum, immunoglobulin deposition in the kidney, and immune complex glomerulonephritis. Resveratrol is an activator of SIRT1 and possesses anti-inflammation and immune-regulatory properties. OBJECTIVE: To evaluate the preventative effects of resveratrol on a pristane-induced lupus animal model and assess its putative immune modulation effects. METHODS: BALB/c mice received a single intraperitoneal injection of 0.5 ml of pristane on day 1 and then various doses of resveratrol were given to the mice daily starting on day 2 and continuing for seven months. The autoantibodies in serum and supernatants were measured. Single cells isolated from spleen, isolated CD4+ T cells, and CD19+ B cells were cultured with or without resveratrol in vitro and assessed by flow cytometry. RESULTS: Resveratrol attenuated proteinuria, immunoglobuin depositon in kidney, and glomerulonephritis as well as IgG1 and IgG2a in serum in pristane-induced lupus mice. Resveratrol also suppressed CD69 and CD71 expression on CD4+ T cells as well as CD4+ T cell proliferation, induced CD4+ T cell apoptosis, and decreased CD4 IFNγ+ Th1 cells and the ratio of Th1/Th2 cells in vitro. In vitro antibody production and proliferation of B cells were also inhibited. CONCLUSION: Resveratrol possesses protective effects in pristane-induced lupus mice and may represent a novel approach for the management of SLE.


Subject(s)
CD4-Positive T-Lymphocytes/drug effects , Inflammation/drug therapy , Lupus Erythematosus, Systemic/drug therapy , Stilbenes/administration & dosage , Animals , Antigens, CD/biosynthesis , Antigens, CD19/metabolism , Antigens, Differentiation, T-Lymphocyte/biosynthesis , Apoptosis/drug effects , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , B-Lymphocytes/pathology , CD4-Positive T-Lymphocytes/immunology , Gene Expression Regulation/drug effects , Humans , Inflammation/chemically induced , Inflammation/immunology , Lectins, C-Type/biosynthesis , Lupus Erythematosus, Systemic/chemically induced , Lupus Erythematosus, Systemic/immunology , Mice , Receptors, Transferrin/biosynthesis , Resveratrol , Sirtuin 1/deficiency , Sirtuin 1/immunology , Terpenes/toxicity
4.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 25(3): 229-32, 2009 Mar.
Article in Chinese | MEDLINE | ID: mdl-19257988

ABSTRACT

AIM: To isolate and purify beta-defensin from the neutrophils of Yak. METHODS: The method of percoll gradient centrifugation was employed to purify neutrophils from Yak peripheral blood. The crude extraction from Yak neutrophils was isolated respectively through a way of extraction by 50 mL/L acetic acid, acid soluble extract of Yak neutrophils was obtained. Then it was further purified by Bio-Gel P-10 Polyacrylamide gel filtration and RP-HPLC, and 9 out of 22 apices showed antibacterial activity. 9 apices showing antibacterial activity were selected to be analyzed by mass spectrograph.The antibacterial activities of the extracts from every step were analyzed by agarose radial diffusion assay. RESULTS: The molecular weight of the purified Yak BNBD-1-3 was determined to be 4.2, 4.6 and 4.8 kDa by mass spectrograph. BNBD-1-3 from Yak neutrophils were able to effectively kill Escherichia coli, Staphylococcus aureus and Bacillus subtilis. CONCLUSION: Yak neutrophils have beta-defensin which have broad-spectrum antimicrobial activity, Yak defensin has an important part in innate immunity.


Subject(s)
Cattle/blood , Neutrophils/metabolism , beta-Defensins/isolation & purification , beta-Defensins/pharmacology , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/isolation & purification , Anti-Bacterial Agents/pharmacology , Bacillus subtilis/drug effects , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Escherichia coli/drug effects , Mass Spectrometry , Molecular Weight , Staphylococcus aureus/drug effects , beta-Defensins/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...